Quantification of mesenchymal stem cells in grafts adds to the benefits of haematopoietic stem cell and T-cell analysis in prediction of the duration of aplasia but not probability of acute graft-versus-host disease: Preliminary results

Dalva, KlaraAyyıldız, ErolErsoy, H.Ertem, Mehmetİkincioğulları, Aydanİlhan, O.Beksaç, Mehmet Sinan2022-03-302022-03-302009-03Dalva, K. vd. (2009). "Quantification of mesenchymal stem cells in grafts adds to the benefits of haematopoietic stem cell and T-cell analysis in prediction of the duration of aplasia but not probability of acute graft-versus-host disease: Preliminary results". Bone Marrow Transplantation, 43, S108-S109.0268-3369http://hdl.handle.net/11452/25459eninfo:eu-repo/semantics/closedAccessBiophysicsOncologyHematologyImmunologyTransplantationQuantification of mesenchymal stem cells in grafts adds to the benefits of haematopoietic stem cell and T-cell analysis in prediction of the duration of aplasia but not probability of acute graft-versus-host disease: Preliminary resultsArticle000264545900270S108S10943BiophysicsOncologyHematologyImmunologyTransplantation